Replies to post #54395 on Intellicell Biosciences Inc (fka SVFC)

[dmatt]

recheck my post .015 -.02 next consolidation. they never go straight up. my target would be around .10 by the Q3
reasoning for this

1. compared to similar stem cell companies eg. ACTC
2. the board of directors assembles is nothing shy of AWSOME with a proven track record of success and multiple connections and contacts in the industry.
3. they have a plan to roll out with 3 clinics this year with projected revs. of 10-20 million per
4. this technology is far cheaper with regards to time and expense as well as no negative reactions


just off the top of my head. too much more to list........